Skip to main content
. 2021 Feb 4;56:26–34. doi: 10.1016/j.breast.2021.02.001

Table 1.

Details regarding the 22 independent patient cohorts included in this systematic review.

Author Year Study Type (LOE) Country BRCA (N) BRCA1 BRCA2 BCS (N) Mastectomy (N) Median age (years) Follow up (months) NOS
Robson 2005 RC (III) US 87 62 25 87 43 76 6
Turner 1999 RC (III) US 8 5 3 8 36 174 5
Garcia-Etienne 2009 RC (III) Italy 54 26 28 54 36 48 6
Yoon 2019 RC (III) Korea 51 33 18 51 44 85 6
Nilsson 2014 RC (III) Sweden 162 45 118 43 155 7
Chiba 2016 RC (III) US 173 100 73 60 109 46 41 6
Haffty 2002 RC (III) US 22 15 7 22 34 168 6
Ye 2020 RC (III) China 63 63 41 61 5
Van den Broek 2018 RC (III) Netherlands 261 190 71 125 136 39 40 6
Robson 1995 RC (III) US 35 27 9 35 124 5
Drooger 2015 RC (III) Netherlands 691 517 174 349 337 109 7
Huang 2020 RC (III) China 176 44 132 48 5
Pierce 2010 RC (III) US 655 394 261 302 353 42 103 6
Kirova 2010 RC (III) France 27 19 8 43 167 5
Pierce 2016 RC (III) US 160 123 37 160 40 95 6
Metcalfe 2011 RC (III) Canada 396 259 142 396 42 126 6
Brekelmens 2007 RC (III) Netherlands 260 90 170 111 135 43 52 6
Eccles 2001 RC (III) UK 75 75 36 39 38 107 7
El Tamer 2004 RC (III) US 51 30 21 21 30 48 79 6
Robson 1998 RC (III) US 30 23 7 9 19 36 66 6
Cao 2019 RC (III) China 103 31 72 103 45 80 6
Foulkes 1997 RC (III) US 12 12 11 45 37 5
Bernstein-Mohlo 2020 RC (III) Israel 255 169 86 127 128 44 71 7

LOE; level of evidence, N; number, BCS; breast conservation surgery, NOS; Newcastle-Ottawa Scale, RC; retrospective cohort, US; United States, UK; United Kingdom.